Series E Preferred Stock Purchase Agreement



 Exhibit 10.7 
 Execution Copy 
  
  
  
 SERIES E PREFERRED STOCK PURCHASE AGREEMENT 
 AMONG 
 THE PRINCETON REVIEW, INC., 
 BAIN CAPITAL VENTURE FUND 2007, L.P., 
 BCVI-TPR INTEGRAL L.P., 
 PRIDES CAPITAL FUND I LP, 
 FALCON STRATEGIC PARTNERS III, LP 
 AND 
 THE OTHER PURCHASERS NAMED ON SCHEDULE I HERETO 
 DATED AS OF DECEMBER 7, 2009 
  
  
  







 TABLE OF CONTENTS 
  

					
	1.	  	Authorization of Securities	  	1
	2.	  	Sale and Purchase of the Series E Preferred Stock	  	2
	3.	  	Closing; Payment of Purchase Price; Use of Proceeds	  	2
	3.1.	  	Closing	  	2
	3.2.	  	Use of Proceeds	  	2
	4.	  	Representations and Warranties of the Purchasers; Register of Securities; Restrictions on Transfer	  	2
	4.1.	  	Organization	  	2
	4.2.	  	Validity	  	3
	4.3.	  	Brokers	  	3
	4.4.	  	Investment Representations and Warranties	  	3
	4.5.	  	Acquisition for Own Account	  	3
	4.6.	  	Ability to Protect Its Own Interests and Bear Economic Risks	  	3
	4.7.	  	Accredited Investor	  	3
	4.8.	  	Access to Information	  	4
	4.9.	  	Restricted Securities	  	4
	4.10.	  	Residence	  	4
	4.11.	  	Series C Preferred Stock	  	4
	5.	  	Representations and Warranties by the Company	  	4
	5.1.	  	Capitalization	  	5
	5.2.	  	Due Issuance and Authorization of Capital Stock	  	6
	5.3.	  	Organization	  	6
	5.4.	  	Subsidiaries	  	6
	5.5.	  	Consents	  	6
	5.6.	  	Authorization; Enforcement	  	6
	5.7.	  	Issuance of Securities	  	7
	5.8.	  	No Conflicts	  	7
	5.9.	  	Material Contracts	  	8
	5.10.	  	Right of First Refusal; Stockholders Agreement; Voting and Registration Rights	  	8
	5.11.	  	Previous Issuances	  	9
	5.12.	  	No Integrated Offering	  	9
	5.13.	  	SEC Reports; Financial Statements	  	9
	5.14.	  	No Undisclosed Material Liabilities	  	10
	5.15.	  	Litigation	  	10
	5.16.	  	Taxes	  	11
	5.17.	  	Employee Matters	  	11
	5.18.	  	Compliance with Laws	  	12
	5.19.	  	Brokers	  	12
	5.20.	  	Environmental Matters	  	12
	5.21.	  	Intellectual Property Matters	  	13
	5.22.	  	Related-Party Transactions	  	16
	5.23.	  	Title to Property and Assets	  	16

  

 -i- 









					
	5.24.	  	Disclosure	  	17
	5.25.	  	Absence of Changes	  	17
	5.26.	  	Illegal Payments	  	18
	5.27.	  	Suppliers and Customers	  	19
	5.28.	  	Regulatory Permits	  	19
	5.29.	  	Insurance	  	19
	5.30.	  	[Reserved.]	  	19
	5.31.	  	Investment Company	  	19
	5.32.	  	Listing and Maintenance Requirements	  	19
	5.33.	  	Accountants	  	20
	5.34.	  	[Reserved.]	  	20
	5.35.	  	Application of Takeover Protections	  	20
	5.36.	  	Stock Options	  	20
	5.37.	  	Acquisition and Financing Documents	  	20
	5.38.	  	Target Representations and Warranties	  	21
	6.	  	Conditions of Parties’ Obligations	  	21
	6.1.	  	Conditions of the Purchasers’ Obligations	  	21
	6.2.	  	Conditions of the Company’s Obligations	  	23
	6.3.	  	Conditions of Each Party’s Obligations	  	24
	7.	  	Covenants	  	24
	7.1.	  	Reporting Requirements; Access to Records	  	24
	7.2.	  	Integration	  	24
	7.3.	  	Securities Laws Disclosure; Publicity	  	25
	7.4.	  	Reservation of Stock	  	25
	7.5.	  	Listing of Common Stock	  	25
	7.6.	  	Filings	  	25
	7.7.	  	Board Representation; Nomination of Chief Executive Officer	  	26
	7.8.	  	Board Committees	  	26
	7.9.	  	Board Observer Rights	  	26
	7.10.	  	Nomination Process	  	27
	7.11.	  	Standstill on Change of Control	  	27
	7.12.	  	Termination of Agreement	  	27
	7.13.	  	Effect of Termination	  	28
	8.	  	Transfer Restrictions; Restrictive Legend	  	28
	8.1.	  	Transfer Restrictions	  	28
	8.2.	  	Unlegended Certificates	  	28
	9.	  	Registration, Transfer and Substitution of Certificates for Securities	  	29
	9.1.	  	Stock Register; Ownership of Securities	  	29
	9.2.	  	Replacement of Certificates	  	29
	10.	  	Definitions	  	29
	11.	  	Enforcement	  	34
	11.1.	  	Cumulative Remedies	  	34
	11.2.	  	No Implied Waiver	  	34
	12.	  	Confidentiality	  	34

  

 -ii- 









					
	13.	  	Miscellaneous	  	35
	13.1.	  	Waivers and Amendments	  	35
	13.2.	  	Notices	  	35
	13.3.	  	Indemnification; Survival	  	37
	13.4.	  	No Waivers	  	38
	13.5.	  	Successors and Assigns	  	38
	13.6.	  	Headings	  	38
	13.7.	  	Governing Law	  	38
	13.8.	  	Independent Nature of Purchasers’ Obligations and Rights	  	38
	13.9.	  	Fees and Expenses	  	39
	13.10.	  	Jurisdiction	  	39
	13.11.	  	Waiver of Jury Trial	  	40
	13.12.	  	Counterparts; Effectiveness	  	40
	13.13.	  	Entire Agreement	  	40
	13.14.	  	Severability	  	40

 LIST OF EXHIBITS 
  

			
	EXHIBIT A	  	Series E Certificate of Designation
	EXHIBIT B	  	Series D Certificate of Designation
	EXHIBIT C	  	Certificate of Elimination
	EXHIBIT D	  	Amended and Restated Investor Rights Agreement
	EXHIBIT E	  	Company By-laws

  

 -iii- 








 SERIES E PREFERRED STOCK PURCHASE AGREEMENT 
 THIS SERIES E PREFERRED STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into
this 7th day of December, 2009 by and among The Princeton
Review, Inc., a Delaware corporation (the “Company”), Bain Capital Venture Fund 2007, L.P., a Delaware limited partnership (“BCVF 2007”), BCVI-TPR Integral L.P., a Delaware limited partnership
(“BCVI”) and, together with BCVF 2007, collectively, “Bain Capital”), Prides Capital Fund I LP, a Delaware limited partnership (“Prides Capital”), and the other entities and
individuals as listed on Schedule I attached hereto (Bain Capital, Prides Capital and such other entities and individuals, collectively, the “Purchasers”). Certain terms used and not otherwise defined in the text of
this Agreement are defined in Section 10 hereof. 
 RECITALS 
 WHEREAS, the Company desires to issue and to sell to each of the Purchasers, and the Purchasers desire to purchase from the Company, the
shares of Series E Preferred Stock (as defined below) set forth opposite such Purchaser’s name on Schedule I attached hereto in the column “Shares Purchased” in consideration of cash and/or shares of the Company’s Series C
Convertible Preferred Stock, par value $0.01 per share (the “Series C Preferred Stock”), currently held by some of the Purchasers, as set forth on Schedule I, all in accordance with the terms and provisions of this
Agreement. 
 AGREEMENT 
 NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties and covenants herein contained, the parties hereto, intending to be legally bound, hereby agree as follows:

 1. Authorization of Securities. The Company has authorized the issuance and sale of an aggregate of up to 98,275
shares of its Series E Non-Convertible Preferred Stock, par value $0.01 per share (the “Series E Preferred Stock”), which will become convertible into shares of Series D Convertible Preferred Stock, par value $0.01 per share
(the “Series D Preferred Stock” and, together with the Series E Preferred Stock, collectively, the “New Preferred Stock”), upon the Series E Preferred Stock Conversion Approval and which will have the
rights, preferences and privileges set forth in the form of Certificate of Designation of Series E Preferred Stock attached hereto as Exhibit A (the “Series E Certificate of Designation”). Upon issuance thereof, the
Series D Preferred Stock will be convertible into shares of the Company’s common stock, par value $0.01 per share (the “Common Stock”), and will have the rights, preferences and privileges set forth in the form of
Certificate of Designation of Series D Preferred Stock attached hereto as Exhibit B (the “Series D Certificate of Designation” and, together with the Series E Certificate of Designation, collectively, the
“Certificates of Designation”). The shares of Common Stock issued or issuable upon conversion of the Series D Preferred Stock are sometimes referred to herein collectively as the “Conversion Shares”
and the shares of Series E Preferred Stock, the shares of Series D Preferred Stock and the Conversion Shares are sometimes referred to herein collectively as the “Securities”. 







 2. Sale and Purchase of the Series E Preferred Stock. Upon the terms and subject to
the conditions herein contained, the Company agrees to sell to each Purchaser, and each Purchaser agrees, severally and not jointly, to purchase from the Company, at the Closing, the number of shares of Series E Preferred Stock set forth in the
column “Shares Purchased” opposite such Purchaser’s name on Schedule I attached hereto, for a purchase price per share equal to $1,000 (the “Purchase Price”), which shall be paid in cash and/or shares of
Series C Preferred Stock, which shares shall be cancelled and retired pursuant to the certificate of elimination attached hereto as Exhibit C, all as set forth in the column “Consideration” opposite such Purchaser’s name on
Schedule I attached hereto. 
 3. Closing; Payment of Purchase Price; Use of Proceeds. 
 3.1. Closing. The closing (the “Closing”) with respect to the transaction contemplated in
Section 2 hereof shall take place at the offices of Ropes & Gray LLP, One International Place, Boston, Massachusetts simultaneously with the closing of the Acquisition, or at such other time and place as the Company and
Purchasers may agree (the “Closing Date”). At the Closing, the Company shall deliver to each Purchaser certificates representing the Series E Preferred Stock which such Purchaser is purchasing at the Closing as set forth on
Schedule I attached hereto, registered in the name of such Purchaser, against delivery to the Company by such Purchaser of a wire transfer and/or shares of Series C Preferred Stock (as the case may be) in the amount of the Purchase Price
therefor. 
 3.2. Use of Proceeds. The Company shall use the proceeds from the sale of Series E Preferred Stock hereunder
to fund the acquisition by the Company of all of the issued and outstanding shares of Penn Foster Education Group, Inc., a Delaware corporation (the “Target”, and such acquisition, the “Acquisition”)
pursuant to the Stock Purchase Agreement, dated as of October 16, 2009 (the “Stock Purchase Agreement”), by and among the Company, Penn Foster Holdings LLC (the “Seller”), the Target and certain
members of the Seller party thereto, to pay all related fees and expenses, to repay all amounts owing under the Company’s or Target’s existing senior secured credit facilities and all other indebtedness and the remainder for working
capital and general corporate purposes. 
 4. Representations and Warranties of the Purchasers; Register of Securities;
Restrictions on Transfer. Each Purchaser (except in the case of Section 4.11, which shall apply only to the Purchasers specified therein), severally as to itself and not jointly, represents and warrants to the Company as follows:

 4.1. Organization. The Purchaser is duly formed or organized, validly existing and in good standing under the laws of
its jurisdiction of organization or formation, and has all requisite corporate, limited liability company, partnership or trust (as the case may be) power and authority to enter into this Agreement and the other Transaction Documents and instruments
referred to herein to which it is a party and to consummate the transactions contemplated hereby and thereby. 
  

 - 2 - 








 4.2. Validity. The execution, delivery and performance of this Agreement and the
other Transaction Documents and instruments referred to herein, in each case to which such Purchaser is a party, and the consummation by such Purchaser of the transactions contemplated hereby and thereby, have been duly authorized by all necessary
action on the part of such Purchaser. This Agreement has been duly executed and delivered by such Purchaser, and the other Transaction Documents and instruments referred to herein to which it is a party will be duly executed and delivered by such
Purchaser, and each such agreement constitutes or will constitute a valid and binding obligation of such Purchaser enforceable against it in accordance with its terms. 
 4.3. Brokers. There is no broker, investment banker, financial advisor, finder or other person which has been retained by or is authorized to act on behalf of such Purchaser who might be entitled
to any fee or commission for which the Company will be liable in connection with the execution of this Agreement and the consummation of the transactions contemplated hereby. 
 4.4. Investment Representations and Warranties. Such Purchaser understands that the offering and sale of the Securities have not been
registered under the Securities Act and are being made in reliance upon federal and state exemptions for transactions not involving a public offering which depend upon, among other things, the bona fide nature of the investment intent and the
accuracy of Purchaser’s representations as expressed herein. The Purchaser acknowledges that, except as set forth in the Amended and Restated Investor Rights Agreement, the Company has no obligation to register or qualify the Securities for
resale. 
 4.5. Acquisition for Own Account. Such Purchaser is acquiring the Securities for its own account for
investment and not with a view toward distribution in a manner which would violate the Securities Act. 
 4.6. Ability to
Protect Its Own Interests and Bear Economic Risks. Such Purchaser, by reason of the business and financial experience of its management, has the capacity to protect its own interests in connection with the transactions contemplated by this
Agreement and the other Transaction Documents. Such Purchaser is able to bear the economic risk of an investment in the Securities and is able to sustain a loss of all of its investment in the Securities without economic hardship if such a loss
should occur. 
 4.7. Accredited Investor. Such Purchaser is an “accredited investor” as that term is defined
in Regulation D promulgated under the Securities Act. 
  

 - 3 - 








 4.8. Access to Information. Such Purchaser has been given access to all Company
documents, records, and other information, and has had adequate opportunity to ask questions of, and receive answers from, the Company’s officers, employees, agents, accountants, and representatives concerning the Company’s business,
operations, financial condition, assets, liabilities, and all other matters relevant to its investment in the Securities. The representations of the Purchasers contained in this Section 4.8 shall not affect the ability of the Purchasers
to rely on the representations and warranties made by the Company pursuant to Section 5 of this Agreement. 
 4.9.
Restricted Securities. 
 (a) Such Purchaser understands that the Securities will be characterized as
“restricted securities” under the federal securities laws inasmuch as they are being acquired from the Company in a transaction not involving a public offering and that under such laws and applicable regulations such Securities may be
resold without registration under the Securities Act only in certain limited circumstances. 
 (b) Such Purchaser
acknowledges that the Securities must be held indefinitely unless subsequently registered under the Securities Act and under applicable state securities laws or an exemption from such registration is available. 
 (c) Such Purchaser is aware of the provisions of Rule 144 under the Securities Act which permit limited resale of securities
purchased in a private placement. 
 4.10. Residence. The office or offices of such Purchaser in which its investment
decision was made, and which is its principal place of business, in the case of a corporation, limited liability company, partnership or other entity, or is its residence, in the case of an individual, is located at the address or addresses of such
Purchaser set forth on Schedule I hereto. 
 4.11. Series C Preferred Stock. Such Purchaser that holds shares of
Series C Preferred Stock as set forth in the column “Consideration” opposite such Purchaser’s name on Schedule I attached hereto is the beneficial owner of such shares and has good and valid title to such shares. Such Purchaser
has full and legal right, power and capacity to tender such shares of Series C Preferred Stock for cancellation as set forth on Schedule I hereto. Upon the Closing, such Purchaser will have no rights in connection with such shares other than
its rights pursuant to this Agreement and the Transaction Documents. 
 5. Representations and Warranties by the Company.
Except as disclosed by the Company in a written Disclosure Schedule provided by the Company to the Purchasers dated the date hereof (the “Disclosure Schedule”), the Company represents and warrants to each Purchaser that the
statements contained in this Section 5 are complete and accurate as of the date of this Agreement. The Disclosure Schedule shall be arranged in sections corresponding to the numbered and lettered sections and subsections contained in
this Section 5, and the disclosures in 
  

 - 4 - 








 
any section or subsection of the Disclosure Schedule shall qualify other sections and subsections in this Section 5 only to the extent it is readily apparent from a reasonable reading
of the disclosure that such disclosure is applicable to such other sections and subsections. For purposes of this Section 5, all references to the “Company” contained herein shall not include the Target. 
 5.1. Capitalization. 
 (a) As of the date hereof, and after giving effect to the filing of the Certificates of Designation and the Closing, the authorized capital stock of the Company consists of 100,000,000 shares of Common
Stock, par value $0.01 per share, and 5,000,000 shares of preferred stock, par value $0.01 per share, of which 300,000 shares are designated Series D Preferred Stock and 98,275 shares are designated Series E Preferred Stock. As of the date hereof,
and after giving effect to the filing of the Certificates of Designation and the Closing, there are 33,727,272 outstanding shares of Common Stock, no outstanding shares of Series D Preferred Stock, 98,275 outstanding shares of Series E Preferred
Stock, 3,169,292 shares of Common Stock are available for issuance upon the exercise of outstanding stock options, warrants, or other convertible rights and 1,822,267 shares of Common Stock are reserved for issuance under the Company’s 2000
Stock Incentive Plan (the “Benefit Plan”). As of the date hereof, and after giving effect to the filing of the Certificates of Designation and the Closing, the Company has no other shares of capital stock authorized, issued
or outstanding. Except for the shares of Series C Preferred Stock held by the Purchasers as set forth in the column “Consideration” opposite such Purchasers’ names on Schedule I attached hereto, there are no other shares of
Series C Preferred Stock outstanding. 
 (b) As of the date hereof, except as set forth on the SEC Reports,
Schedule 5.1(b) or as described in Section 5.1(a); except as may be granted or required by this Agreement and the other Transaction Documents; and except for the obligation to issue 4,275 shares of Series E Preferred Stock
pursuant to the Financing Documents, (i) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities or rights convertible into or exercisable or
exchangeable for, any shares of capital stock of the Company, or arrangements by which the Company is or may become bound to issue additional shares of capital stock, nor are any such issuances or arrangements contemplated; (ii) there are no
agreements or arrangements under which the Company is or may become obligated to register the sale of any of its securities under the Securities Act; (iii) the Company has no obligation (contingent or otherwise) to purchase, redeem or otherwise
acquire any of its equity securities or any interests therein or to pay any dividend or make any distribution in respect thereof; and (iv) the Company has not reserved any shares of capital stock for issuance pursuant to any stock option plan
or similar arrangement. 
  

 - 5 - 








 5.2. Due Issuance and Authorization of Capital Stock. All of the outstanding shares
of capital stock of the Company have been validly issued and are fully paid and non-assessable. The sale and delivery of the shares of Series E Preferred Stock to the Purchasers, when issued, sold and delivered in accordance with the terms and for
the consideration hereof, and the issuance of the shares of Series D Preferred Stock upon conversion of the shares of Series E Preferred Stock and the issuance of the Conversion Shares upon conversion of the shares of Series D Preferred Stock will
vest in the holders thereof legal and valid title to such Securities, free and clear of any lien, claim, judgment, charge, mortgage, security interest, pledge, escrow, equity or other encumbrance (collectively,
“Encumbrances”). 
 5.3. Organization. The Company and each of its Subsidiaries (a) is duly
incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its formation, except, in the case of its Subsidiaries, where the failure to be so incorporated or organized would not have a Material
Adverse Effect, (b) is duly qualified to do business as a foreign entity and is in good standing in each jurisdiction where the nature of the property owned or leased by it or the nature of the business conducted by it makes such qualification
necessary, except where the failure to be so qualified would not have a Material Adverse Effect, and (c) has all requisite corporate power and authority to own or lease and operate its assets and carry on its business as presently being
conducted. The Company has its principal place of business and chief executive office in Framingham, Massachusetts. 
 5.4.
Subsidiaries. All of the direct and indirect Subsidiaries of the Company are set forth on the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any
Encumbrances, and all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. 
 5.5. Consents. Assuming the accuracy of the representations made by the Purchasers in Section 4 of this Agreement,
neither the execution, delivery or performance of the Certificates of Designation, this Agreement, the other Transaction Documents, the Financing Documents, the Stock Purchase Agreement or the Acquisition Documents by the Company, nor the
consummation by it of the obligations and transactions contemplated hereby or thereby (including, without limitation, the issuance, the reservation for issuance and the delivery, as applicable, of the New Preferred Stock or the issuance and delivery
of the Conversion Shares) requires any consent of, authorization by, exemption from, filing with or notice to any Governmental Entity or any other Person, other than (a) the filing of the Certificates of Designation with the Secretary of State
of the State of Delaware, (b) the filings required to comply with the Company’s registration obligations under the Amended and Restated Investor Rights Agreement and (c) filings required under applicable U.S. federal and state
securities laws. 
 5.6. Authorization; Enforcement. The Company has, or as of the Closing will have, all requisite
corporate power and has, or as of the Closing will have, taken all necessary corporate action required for the due authorization, execution, delivery and performance by the Company of this Agreement, the Financing Documents, the Stock Purchase
Agreement, the 
  

 - 6 - 








 
Acquisition Documents and the other Transaction Documents and the consummation of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Securities
and the provision to the Purchasers of the rights contemplated by the Transaction Documents) and no action on the part of the stockholders of the Company is required other than obtaining the Series E Preferred Stock Conversion Approval and the
approval of the holders of Series C Preferred Stock. The execution, delivery and performance by the Company of each of the Transaction Documents, the execution and filing of the Certificates of Designation, and the consummation by the Company of the
transactions contemplated hereby and thereby have been duly authorized by all necessary corporate action on the part of the Company. This Agreement has been duly executed and delivered by the Company, and the other Transaction Documents and
instruments referred to herein to which it is a party will be duly executed and delivered by the Company, and each such agreement constitutes or will constitute a valid and binding obligation of the Company enforceable against it in accordance with
its terms, subject to bankruptcy, insolvency, fraudulent conveyance or other similar laws affecting creditors’ rights generally and to general equitable principles. 
 5.7. Issuance of Securities. The Securities, when issued, sold and delivered in accordance with the terms and for the consideration set forth in this Agreement, will be duly authorized and,
assuming conversion on the date hereof, a sufficient number of shares of authorized but unissued shares of Common Stock and Series D Preferred Stock have been reserved for issuance upon conversion of the Series D Preferred Stock and the Series E
Preferred Stock, respectively, and upon such issuance or conversion in accordance with the terms of this Agreement, the Series D Certificate of Designation or the Series E Certificate of Designation, as the case may be, all such Securities will be
duly authorized, validly issued, fully paid and non-assessable, and free from all taxes and Encumbrances and will not be subject to preemptive rights or other similar rights of stockholders of the Company, and the issuance of such shares will not
impose personal liability upon the holder thereof. 
 5.8. No Conflicts. The execution, delivery and performance of each
of the Transaction Documents, the Financing Documents, the Stock Purchase Agreement and the Acquisition Documents; the execution and filing of the Certificates of Designation; and the consummation of the Financings, the Acquisition and the
transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance, as applicable, of the New Preferred Stock and the Conversion Shares) will not (a) result in a violation of the Amended and
Restated Certificate of Incorporation and By-laws of the Company (collectively, the “Charter Documents”) or the certificates of formation, operating agreements, certificates of incorporation or by-laws of any of its
Subsidiaries, (b) conflict with or result in the breach of the terms, conditions or provisions of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give rise to any right of
termination, acceleration or cancellation under, any agreement, lease, mortgage, license, indenture, instrument or other contract to which the Company or any Subsidiary is a party, (c) result in a material violation of any law, rule,
regulation, order, judgment or decree (including, without limitation, U.S. federal and state securities laws and regulations) applicable to the Company or any 
  

 - 7 - 








 
Subsidiary or by which any property or asset of the Company or any Subsidiary is bound or affected, (d) result in a material violation of any rule or regulation of FINRA or the
Company’s Trading Markets, or (e) except pursuant to the Financing Documents, result in the creation of any Encumbrance upon any of the Company’s or any Subsidiary’s assets, except, in the case of clauses (b) or
(e), for any such conflicts, violations, breaches, defaults or other occurrences that would not have, individually or in the aggregate, a Material Adverse Effect. The Company is not in material violation of its Charter Documents and neither
the Company nor any Subsidiary is in material default (and no event has occurred which, with notice or lapse of time or both, would cause the Company to be in material default) under, nor has there occurred any event giving others (with notice or
lapse of time or both) any rights of termination, amendment, acceleration or cancellation of, any Material Contract. The business of the Company and its Subsidiaries is not being conducted in violation in any material respect of any law, ordinance
or regulation of any Governmental Entity except for such violations that would not have a Material Adverse Effect. 
 5.9.
Material Contracts. Each Material Contract is the legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability may be limited by bankruptcy,
insolvency, fraudulent conveyance or other similar laws affecting creditors’ rights generally and by general equitable principles. There has not occurred any breach, violation or default or any event that, with the lapse of time, the giving of
notice or the election of any Person, or any combination thereof, would constitute a breach, violation or default by the Company under any such Material Contract or, to the knowledge of the Company, by any other Person to any such contract, except
for such violations or defaults that would not have a Material Adverse Effect. To the knowledge of the Company, it has not been notified that any party to any Material Contract intends to cancel, terminate, not renew or exercise an option under any
Material Contract, whether in connection with the transactions contemplated hereby or otherwise. 
 5.10. Right of First
Refusal; Stockholders Agreement; Voting and Registration Rights. Except pursuant to any agreement listed as an exhibit to SEC Reports, this Agreement or the other Transaction Documents, no party has any right of first refusal, right of first
offer, right of co-sale, preemptive right or other similar right regarding the equity securities of the Company. Except pursuant to any agreement listed as an exhibit to SEC Reports or, in the case of (e) below, except for the Financing
Documents, there are no provisions of the Charter Documents, no Material Contracts other than the Certificates of Designation, this Agreement or the other Transaction Documents, which (a) may affect or restrict the voting rights of the
Purchasers with respect to the Securities in their capacity as stockholders of the Company, (b) restrict the ability of the Purchasers, or any successor thereto or assignee or transferee thereof, to transfer the Securities, (c) would
adversely affect the Company’s or any Purchaser’s right or ability to consummate the transactions contemplated by this Agreement or comply with the terms of the other Transaction Documents or the Certificates of Designation and the
transactions contemplated hereby or thereby, (d) require the vote of more than a majority of the Company’s issued and outstanding Common Stock, voting together as a single class, to take or prevent any 
  

 - 8 - 








 
corporate action, other than those matters requiring a different vote under Delaware law, or (e) entitle any party to nominate or elect any director of the Company or require any of the
Company’s stockholders to vote for any such nominee or other person as a director of the Company in each case above. 
 5.11. Previous Issuances. All shares of capital stock and other securities issued by the Company prior to the Closing Date have been issued in transactions registered under or exempt from the registration requirements under the
Securities Act and all applicable state securities or “blue sky” laws, and in compliance with all applicable corporate laws. The Company has not violated the Securities Act or any applicable state securities or “blue sky” laws in
connection with the issuance of any shares of capital stock or other securities prior to the Closing Date. 
 5.12. No
Integrated Offering. Neither the Company, nor any of its Affiliates or any other Person acting on the Company’s behalf, has directly or indirectly engaged in any form of general solicitation or general advertising with respect to the
Securities nor have any of such Persons made any offers or sales of any security of the Company or its Affiliates or solicited any offers to buy any security of the Company or its Affiliates under circumstances that would require registration of the
Securities under the Securities Act or cause this offering of Securities to be integrated with any prior offering of securities of the Company for purposes of the Securities Act or any applicable shareholder approval provisions of any Trading Market
on which any of the securities of the Company are listed or designated. 
 5.13. SEC Reports; Financial Statements.

 (a) Except as disclosed on the SEC Reports, the Company has filed all reports, schedules, forms, statements
and other documents required to be filed by the Company under the Securities Act and the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (the foregoing materials, including the
exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any such
SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not
misleading; provided that, if the Company has previously amended any of its SEC Reports, such amendment shall not mean or imply that the foregoing representation or warranty is not true and correct. All Material Contracts to which the Company
is a party or to which the property or assets of the Company are subject are required to be included as part of or specifically identified in the SEC Reports are so included or specifically identified. Except as disclosed to the

  

 - 9 - 








 
Purchasers in writing, the Company has filed all SEC Reports required to be filed with the SEC since December 31, 2006 (the “Post-2006 SEC Reports”); provided
that, if the Company amends any of its Post-2006 SEC Reports, such amendment shall not mean or imply that any representation or warranty in this Agreement was not true and correct when made or became untrue thereafter. 
 (b) The financial statements of the Company included in the SEC Reports comply in all material respects with applicable
accounting requirements and the rules and regulations of the SEC with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial
statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries as of
and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments. 
 5.14. No Undisclosed Material Liabilities. As of the date of this Agreement, there are no liabilities of the Company, of any kind
whatsoever, whether interest-bearing indebtedness, or liabilities accrued, contingent, absolute, determined, determinable or otherwise, other than liabilities: 
 (a) reflected in the financial statements included in the SEC Reports; 
 (b) incurred in the ordinary course of business, consistent with past practice; 
 (c) created under, or incurred in connection with, this Agreement, the other Transaction Documents, the Certificates of
Designation, the Financing Documents, or the Acquisition Documents; or 
 (d) which would not in the aggregate be
material to the Company. 
 5.15. Litigation. There is no action, suit, investigation or other proceeding pending
against, or to the knowledge of the Company, threatened against or affecting, the Company or any of its Subsidiaries or any of their properties or to the knowledge of the Company any of its or their officers or directors before any court or
arbitrator or any Governmental Entity that could cause a Material Adverse Effect, except as disclosed in the SEC Reports or as set forth on Schedule 5.15. To the knowledge of the Company, there are no facts that would cause a reasonable
person to believe that such a proceeding would likely result. 
  

 - 10 - 








 5.16. Taxes. The Company and each of its Subsidiaries has properly filed all federal,
foreign, state, local, and other tax returns and reports which are required to be filed, which returns and reports were properly completed and are true and correct in all respects, and all taxes, interest, and penalties due and owing have been
timely paid, except for those taxes, interest or penalties which would not have a Material Adverse Effect. Except as set forth on Schedule 5.16, there are no outstanding waivers or extensions of time with respect to the period for assessing
or auditing any tax or tax return of the Company or any Subsidiary, or claims now pending or matters under discussion between the Company or any Subsidiary and any taxing authority in respect of any tax of the Company or any Subsidiary. 

5.17. Employee Matters. 
 (a) The Company has listed any “employee benefit plan” subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), that it maintains for
employees on any agreement listed as an exhibit to an SEC Report or on Schedule 5.17(a). 
 (b) Except as
set forth on the SEC Reports, (i) no director or officer or other employee of the Company will become entitled to any retirement, severance or similar benefit or enhanced or accelerated benefit (including any acceleration of vesting) or lapse
of repurchase rights or obligations with respect to any employee benefit plan subject to ERISA or other benefit under any compensation plan or arrangement of the Company (each, an “Employee Benefit Plan”)) solely as a result
of the transactions contemplated in this Agreement; and (ii) no payment made or to be made to any current or former employee or director of the Company, or any of its Affiliates by reason of the transactions contemplated hereby (whether alone
or in connection with any other event, including, but not limited to, a termination of employment) will constitute an “excess parachute payment” within the meaning of Section 280G of the Code. 
 (c) No executive officer, to the knowledge of the Company, is, or is now expected to be, in violation of any term of any
employment contract, confidentiality, disclosure or proprietary information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant, and, to the knowledge of the Company, the continued employment of
each such executive officer does not subject the Company or any of its Subsidiaries to any liability with respect to any of the foregoing matters, except for such violations which would not have a Material Adverse Effect. 
 (d) Except as set forth on Schedule 5.17(d), the Company and its Subsidiaries are in compliance with all applicable
federal, state, local and foreign statutes, laws (including, without limitation, common law), judicial decisions, regulations, ordinances, rules, judgments, orders and codes respecting employment, employment practices, labor, terms and conditions of
employment and wages and hours, and no work stoppage or labor strike against the Company or any Subsidiary is pending or, to their knowledge, threatened, nor is the Company or any Subsidiary involved in or, to their knowledge, threatened with any
labor dispute, grievance or litigation relating to

  

 - 11 - 








 
labor matters involving any employees of the Company or any Subsidiary, except for any of the foregoing which would not have a Material Adverse Effect. To the Company’s knowledge, there are
no suits, actions, disputes, claims (other than routine claims for benefits), investigations or audits pending or, to the knowledge of the Company, threatened in connection with any Employee Benefit Plan. 
 5.18. Compliance with Laws. Except as set forth on Schedule 5.18, the Company and its Subsidiaries have, and are in compliance
with the terms of, all franchises, permits, licenses and other rights and privileges necessary to conduct the Company’s present and proposed business and are in compliance with and have not violated, in any respect, any applicable provisions of
any laws, statutes, ordinances or regulations or the terms of any judgments, orders, decrees, injunctions or writs, except for any of the foregoing which would not have a Material Adverse Effect. 
 5.19. Brokers. There is no investment banker, broker, finder, financial advisor or other person which has been retained by or is
authorized to act on behalf of the Company who is entitled to any fee or commission in connection with the transactions contemplated by this Agreement. 
 5.20. Environmental Matters. 
 (a)(i) No written notice,
notification, demand, request for information, citation, summons, complaint or order has been received by, and no investigation, action, claim, suit, proceeding or review is pending or, to the knowledge of the Company, threatened by any Person
against the Company or any of its Subsidiaries and no penalty has been assessed against the Company or any of its Subsidiaries, in each case, with respect to any matters relating to or arising out of any Environmental Law; (ii) the Company and
its Subsidiaries are in material compliance with all applicable Environmental Laws; and (iii) to the knowledge of the Company, there are no material liabilities of or relating to the Company and its Subsidiaries relating to or arising out of
any Environmental Law, and there is no existing condition, situation or set of circumstances which could reasonably be expected to result in a such a liability. 
 (b) For purposes of this Agreement, the term “Environmental Laws” means federal, state, local and
foreign statutes, laws, binding judicial decisions, regulations, ordinances, rules, binding judgments, binding orders, codes, binding injunctions and permits relating to human health and the environment, including, but not limited to, Hazardous
Materials; and the term “Hazardous Material” means all substances or materials regulated as hazardous, toxic, explosive, dangerous, flammable or radioactive under any Environmental Law including, but not limited to:
(i) petroleum, asbestos, or polychlorinated biphenyls and (ii) in the United States, all substances defined as Hazardous Substances, Oils, Pollutants or Contaminants in the National Oil and Hazardous Substances Pollution Contingency Plan.

  

 - 12 - 








 5.21. Intellectual Property Matters. 
 (a) “Intellectual Property” means any and all of the following arising under the laws of the United
States, any other jurisdiction or any treaty regime: (i) all inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereon, and all patents, patent applications and patent disclosures and all
reissuances, continuations, continuations-in-part, divisionals, revisions, extensions and reexaminations thereof, (ii) all trademarks, service marks, trade dress, logos, trade names and corporate names and all translations, adaptations,
derivations and combinations thereof and including all goodwill associated therewith, and all applications, registrations and renewals in connection therewith, (iii) all copyrightable works, mask works or moral rights, all copyrights and all
applications, registrations and renewals in connection therewith, (iv) all trade secrets and confidential business information (including, without limitation, ideas, research and development, know-how, formulas, compositions, manufacturing and
production processes and techniques, technical data, designs, drawings, specifications, customer and supplier lists, pricing and cost information and business and marketing plans and proposals), (v) all computer software (including, without
limitation, data and related documentation and except for any commercial “shrink-wrapped” software) and source codes, (vi) all other proprietary rights, (vii) all copies and tangible embodiments of the foregoing (in whatever form
or medium) and (viii) all licenses or agreements in connection with the foregoing. “Company Intellectual Property” means all Intellectual Property which is used in connection with, and is material to, the business of the
Company and its Subsidiaries and all Intellectual Property owned by the Company and its Subsidiaries, provided that any Intellectual Property that is licensed by the Company or any of its Subsidiaries shall be included within the meaning of
Company Intellectual Property only within the scope of use by the Company and its Subsidiaries or in connection with the Company’s business. 
 (b) Except pursuant to the Financing Documents or as disclosed in the SEC Reports or as set forth on
Schedule 5.21(b), with respect to each item of Company Intellectual Property: 
 (1) the Company or its
Subsidiary possesses all rights, titles and interests in and to the item if owned by the Company or its Subsidiary, free and clear of any Encumbrance, license or other restriction, except where the failure to possess such rights, titles and
interests or the existence of any such Encumbrance, license or other restriction would not have a Material Adverse Effect, and possesses all rights necessary in the case of a licensed item to use such item in the manner in which it presently uses
the item or reasonably contemplates using such item, and the Company has taken or caused to be taken reasonable and prudent steps to protect its rights in and to, and the validity and enforceability of, the item owned by the Company or its
Subsidiary; 
  

 - 13 - 








 (2) the item, if owned by the Company or its Subsidiary, is not, and if
licensed, to the knowledge of the Company is not, subject to any outstanding injunction, judgment, order, decree, ruling or charge naming the Company or a Subsidiary; 
 (3) no action, suit, proceeding, hearing, investigation, charge, complaint, claim or demand is pending or, to the knowledge
of the Company, has been or is being threatened which challenges the legality, validity, enforceability, use or ownership of the item; 
 (4) to the knowledge of the Company, the Company or its Subsidiary has sufficient right, title and interest to use or own the item without infringement upon any Intellectual Property Right or other right
of any third party, except for such failure which would not have a Material Adverse Effect; 
 (5) except in the
ordinary course of business and to the knowledge of the Company, the Company and its Subsidiaries have not agreed to indemnify any person for or against any interference, infringement, misappropriation or other conflict with respect to the item;

 (6) to the knowledge of the Company, no third party has interfered with, infringed upon, misappropriated or
otherwise come into conflict with the Company Intellectual Property, except for such interference, infringement or misappropriation which would not have a Material Adverse Effect; 
 (7) neither the Company nor any Subsidiary is party to any option, license, sublicense or agreement or permission of any kind
covering the item that it is in breach or default thereunder, and no event has occurred which, with notice or lapse of time, would constitute a breach or default or permit termination, modification or acceleration thereunder, except for such breach
or default which would not have a Material Adverse Effect; and 
 (8) to the knowledge of the Company, each
option, license, sublicense, agreement or permission of any kind covering the item is legal, valid, binding, enforceable against the Company or its Subsidiary, as the case may be, and in full force and effect. 
 All applications for, pending or registered patents, copyrights, trademarks, and service marks in the United States and any
other jurisdiction (x) if owned by the Company or a Subsidiary, and (y) if licensed, to the knowledge of the Company, are valid and subsisting and in full force and effect or are currently pending and are not subject to any claims,
Encumbrances, taxes or other fees except for periodic filing and maintenance fees. Except as set forth on Schedule 5.21(b) and except for such infringement or

  

 - 14 - 








 
misappropriation which would not have a Material Adverse Effect, the Company and its Subsidiaries have not, to the knowledge of the Company, infringed upon, misappropriated or otherwise come into
conflict with any Intellectual Property rights of third parties, and there is no pending or, to the knowledge of the Company, threatened claim or litigation against the Company or any Subsidiary contesting the right to use any third party’s
Intellectual Property rights, asserting the misuse of any thereof, or asserting the infringement or other violation thereof. 
 (c) All domain names owned by the Company or its Subsidiaries and material to the business of the Company and its Subsidiaries (the “Domain Names”) have been and are duly
registered with Network Solutions, Inc. (“NSI”) through NSI’s registration procedures, and are operating, accessible domain names. The Company or a Subsidiary owns and, to the best of the Company’s knowledge, has
not waived, forfeited or granted to any third parties, any rights, title or interest in or to the Domain Names including, without limitation, any benefits, entitlements or rights of renewal with respect to the Domain Names. NSI has not notified the
Company or any Subsidiary that any of the Domain Names have been placed on “hold” or are otherwise subject to a dispute or potential dispute pursuant to NSI’s dispute resolution policy. 
 (d) To the knowledge of the Company, none of the key employees of the Company or any Subsidiary are obligated under any
contract (including, without limitation, licenses, covenants, or commitments of any nature) or other agreement, or subject to any judgment, decree, or order of any court or administrative agency, that would interfere with the use of his or her
reasonable diligence to promote the interests of the Company or that would conflict with the Company’s businesses as presently conducted. Neither the execution, delivery or performance of this Agreement, nor the carrying on of the
Company’s businesses by the employees of the Company and its Subsidiaries, nor the conduct of the Company’s businesses as presently conducted, will conflict with or result in a breach of the terms, conditions or provisions of, or
constitute a default under, any contract, covenant, or instrument under which any such key employee is obligated, and which conflict, breach or default would have a Material Adverse Effect. 
 (e) The Company has entered into reasonable non-compete, confidentiality and proprietary information and assignment of
inventions and other Intellectual Property agreements with the executive officers of the Company and its Subsidiaries seeking to protect, among other things, the confidentiality of all Company Intellectual Property and to ensure full and
unencumbered ownership by the Company or a Subsidiary of all Company Intellectual Property. The Company is not aware of any violation by any such employees of such agreements. 
 (f) No member, director, officer, employee or, to the knowledge of the Company, stockholder, of the Company or any subsidiary
has any interest, right, title or interest in any of the Company Intellectual Property. 
  

 - 15 - 








 (g) The Company Intellectual Property comprises all Intellectual Property
necessary to the Company’s business as presently conducted or proposed to be conducted by it. The Company does not believe it is or will be necessary to utilize any inventions, trade secrets or proprietary information of any of its employees
made prior to their employment by the Company or a Subsidiary, except for inventions, trade secrets or proprietary information that have been assigned to the Company or a Subsidiary. 
 (h) The Company and its Subsidiaries are not subject to any “open source” or “copyleft” obligations or
otherwise required to make generally available, or make any public disclosure of, any source code either used or developed by the Company or any Subsidiary except as would not have a Material Adverse Effect. 
 (i) Except as set forth on Schedule 5.21(i), all material databases, hardware, technology and software used by the
Company and its Subsidiaries perform in substantial compliance with applicable specifications. 
 (j) Except as
set forth on Schedule 5.21(j), the Company and its Subsidiaries maintain policies and procedures regarding data security, privacy and data use that are commercially reasonable and, in any event, comply with the Company’s obligations to
its customers and applicable laws, rules and regulations. To the knowledge of the Company, there have not been, and the transaction contemplated under this Agreement will not result in, any security breaches of any security policy, data use
restriction or privacy breach under any such policies or any applicable laws, rules or regulations. 
 5.22. Related-Party
Transactions. Except as set forth on the SEC Reports or as contemplated by this Agreement, the other Transaction Documents or the Financing Documents, no stockholder who beneficially owns five percent (5%) or more (on a fully-diluted basis)
of any class of equity securities, officer or director of the Company or any Subsidiary or member of his or her immediate family is currently indebted to the Company or any Subsidiary, nor is the Company or any Subsidiary indebted (or committed to
make loans or extend or guarantee credit) to any of such individuals. Except as set forth in the SEC Reports or as contemplated by this Agreement, the other Transaction Documents or the Financing Documents, as of the date hereof, no stockholder who
beneficially owns five percent (5%) or more (on a fully-diluted basis) of any class of equity securities, officer or director of the Company and no member of the immediate family of any stockholder who beneficially owns five percent
(5%) or more (on a fully-diluted basis) of any class of equity securities, officer or director of the Company is directly or indirectly interested in any contract with the Company. 
 5.23. Title to Property and Assets. Neither the Company nor any Subsidiary owns any real property. Except as set forth on the SEC
Reports, pursuant to the Financing Documents, or as would not have a Material Adverse Effect, the Company and its Subsidiaries own or have legally enforceable rights to use or hold for use their personal property and assets 
  

 - 16 - 








 
free and clear of all Encumbrances except liens for taxes not yet due and payable, purchase-money security interests entered into in the ordinary course of business and such other Encumbrances,
if any, that individually or in the aggregate, do not and would not detract from the value of any asset or property of the Company and its Subsidiaries or interfere with the use or contemplated use of any personal property of the Company and its
Subsidiaries. With respect to any real property, neither the Company nor any Subsidiary is in violation in any respect of any of its leases, except for any such violations as would not have a Material Adverse Effect. All machinery, equipment,
furniture, fixtures and other personal property and all buildings, structures and other facilities, if any, including, without limitation, office or other space used by the Company and its Subsidiaries in the conduct of their business, are in good
operating condition and fit for operation in the ordinary course of business (subject to normal wear and tear) except for any defects which in the aggregate would not have a Material Adverse Effect. 
 5.24. Disclosure. The Company understands and confirms that the Purchasers will rely on the foregoing representation in effecting
transactions in securities of the Company. No representation or warranty by the Company contained in this Agreement contains any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made
therein, in light of the circumstances under which they were made, not misleading. The Company acknowledges and agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other
than those specifically set forth in Section 4 hereof. Except for the representations and warranties contained in this Section 5, neither the Company nor any other person or entity acting on behalf of the Company, makes any
representation or warranty, express or implied. 
 5.25. Absence of Changes. Since the date of the latest audited
financial statements included within the SEC Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof or as set forth on Schedule 5.25 or as contemplated by this Agreement, or in connection with the
Certificates of Designation, this Agreement, the other Transaction Documents, the Acquisition Documents or the Financing Documents, there has not been: 
 (1) other than with respect to the Series C Preferred Stock in accordance with its terms, any declaration, setting aside or payment of any dividend or other distribution with respect to any shares of
capital stock of the Company or any repurchase, redemption or other acquisition by the Company of any outstanding shares of its capital stock of the Company; 
 (2) any amendment of any term of any outstanding security of the Company; 
 (3) any (A) grant of any severance or termination pay to (or amendment to any such existing arrangement with) any
director or executive officer of the Company or any Subsidiary, (B) entering into of any employment,

  

 - 17 - 








 
deferred compensation, supplemental retirement or other similar agreement (or any amendment to any such existing agreement) with any director or executive officer of the Company or any
Subsidiary, (C) increase in, or accelerated vesting and/or payment of, benefits under any existing severance or termination pay policies or employment agreements with any director or executive officer of the Company or any Subsidiary or
(D) increase in or enhancement of any rights or features related to compensation, bonus or other benefits payable to directors or executive officers of the Company or any Subsidiary, in each case, other than in the ordinary course of business
consistent with past practice; 
 (4) any Material Adverse Effect or any event or events that individually or in
the aggregate would have a Material Adverse Effect; 
 (5) any damage, destruction or loss (whether or not
covered by insurance) materially and adversely affecting the Company’s and its Subsidiaries’ properties or assets when taken as a whole; 
 (6) any sale, assignment or transfer, or any agreement to sell, assign or transfer, any material asset, liability, property, obligation or right of the Company to any Person, including, without
limitation, the Purchasers and their respective Affiliates, in each case, other than in the ordinary course of business and consistent with past practice; 
 (7) any waiver of any rights or claims of the Company or any Subsidiary, except for such waivers which would not have a Material Adverse Effect; 
 (8) any agreement or commitment by the Company or any Subsidiary to do any of the foregoing or any transaction by the Company
or any Subsidiary outside the ordinary course of business of the Company; or 
 (9) any lien upon, or adversely
affecting, any property or other assets of the Company or any Subsidiary, except for such liens which would not have a Material Adverse Effect. 
 5.26. Illegal Payments. Neither the Company nor any Subsidiary has, nor, to the knowledge of the Company, has any director, officer, agent or employee of the Company or any Subsidiary, paid, caused
to be paid, or agreed to pay, directly or indirectly, in connection with the business of the Company: (a) to any government or agency thereof, any agent or any supplier or customer, any bribe, kickback or other similar payment; (b) any
contribution to any political party or candidate (other than from personal funds of directors, officers or employees not reimbursed by their respective employers or as otherwise permitted by applicable law); or (c) intentionally established or
maintained any unrecorded fund or asset or made any false entries on any books or records for any purpose. 
  

 - 18 - 








 5.27. Suppliers and Customers. The Company does not have any knowledge of any
termination, cancellation or threatened termination or cancellation or limitation of, or any dissatisfaction with, the business relationship between the Company or any Subsidiary and any supplier, customer, vendor, customer or client, except for any
of the foregoing which would not have a Material Adverse Effect or as set forth on Schedule 5.27 hereto. 
 5.28.
Regulatory Permits. The Company and its Subsidiaries possess all certificates, authorizations and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as
described in the SEC Reports, except where the failure to possess such permits could not have or reasonably be expected to result in a Material Adverse Effect (“Material Permits”), and neither the Company nor any Subsidiary
has received any notice of proceedings relating to the revocation or modification of any Material Permit. 
 5.29.
Insurance. The Company and its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as are customary in the businesses in which the Company and the Subsidiaries are
engaged. Neither the Company nor any Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to
continue its business without a significant increase in cost. 
 5.30. [Reserved.] 
 5.31. Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the shares of
Series E Preferred Stock, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as amended. 
 5.32. Listing and Maintenance Requirements. The Common Stock is registered pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to
its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company received any notification that the SEC is contemplating terminating such registration. The Company has not, in
the twelve (12) months preceding the date hereof, received notice from any Trading Market on which the Common Stock is or has been listed or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements
of such Trading Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing and maintenance requirements. 
  

 - 19 - 








 5.33. Accountants. PricewaterhouseCoopers LLP, Grant Thornton LLP and
Ernst & Young LLP, who each expressed their opinion with respect to the consolidated financial statements included in the SEC Reports, are independent accountants as required by the Securities Act and the rules and regulations promulgated
thereunder. There are no disagreements of any kind presently existing, or reasonably anticipated by the Company to arise, between the Company and the independent registered public accounting firm formerly or presently employed by the Company and the
Company is current with respect to any fees owed to such accounting firm. 
 5.34. [Reserved.] 
 5.35. Application of Takeover Protections. The Company and the Board have taken all necessary action, if any, in order to render
inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s certificate or articles of incorporation, bylaws
(or other organizational or charter documents) or the laws of its state of incorporation (including Section 203 of the Delaware General Corporation Law) that is or could become applicable to the Purchasers as a result of the Purchasers and the
Company fulfilling their obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company’s issuance of the Series E Preferred Stock or the issuance and delivery of the Series D
Preferred Stock upon conversion of the Series E Preferred Stock or the issuance and delivery of the Conversion Shares upon conversion of the Series D Preferred Stock and the Purchasers’ ownership of the Series E Preferred Stock, the Series D
Preferred Stock and the Conversion Shares, as the case may be. 
 5.36. Stock Options. With respect to stock options
issued pursuant to the Company’s Employee Benefit Plans (i) each stock option designated by the Company at the time of grant as an “incentive stock option” under Section 422 of the Code so qualifies, (ii) except as
disclosed in the SEC Reports, including the financial statements included therein, each grant of a stock option was duly authorized no later than the date on which the grant of such stock option was by its terms to be effective by all necessary
corporate action, including, as applicable, approval by the Board (or a duly constituted and authorized committee thereof) and any required stockholder approval by the necessary number of votes or written consents, (iii) each such grant was
made in accordance with the material terms of the Employee Benefit Plans, the Securities Act and all other applicable laws and regulatory rules or requirements, and (iv) each such grant was or has now been properly accounted for in accordance
with GAAP in the financial statements (including the related notes) of the Company and disclosed in the SEC Reports in accordance with the Exchange Act and all other applicable laws. 
 5.37. Acquisition and Financing Documents. The Company has provided to the Purchasers true and complete copies of the Stock Purchase
Agreement, the Acquisition Documents and the Financing Documents. Each such agreement is the legal, valid and binding obligation of the Company, enforceable in accordance with its terms, subject to bankruptcy, insolvency, fraudulent conveyance or
other similar laws affecting creditors’ rights generally and to general equitable principles. 
  

 - 20 - 








 5.38. Target Representations and Warranties. The representations and warranties of
Target and Seller contained in the Stock Purchase Agreement and the Acquisition Documents are true and correct in all material respects. 
 6. Conditions of Parties’ Obligations. 
 6.1. Conditions of the
Purchasers’ Obligations. The obligations of each of the Purchasers to purchase the shares of Series E Preferred Stock set forth on Schedule I attached hereto at the Closing are subject to the fulfillment prior to the Closing of all
of the following conditions, any of which may be waived in whole or in part by such Purchaser severally as to itself and not jointly in its absolute discretion. 
 (a) Company Performance. The Company shall have performed and complied in all material respects with all agreements,
obligations and conditions contained in this Agreement that are required to be performed or complied with it on or before the Closing. 
 (b) Certificates of Designation. Prior to the Closing, (i) the Certificates of Designation shall have been filed with and accepted by the Secretary of State of the State of Delaware, and
(ii) the Purchasers shall have received confirmation from the Secretary of State of the State of Delaware reasonably satisfactory to them that such filings and acceptances have occurred. 
 (c) Acquisition. Simultaneously with or prior to the Closing hereunder, the closing of the Acquisition shall have
occurred on the terms and conditions of the Stock Purchase Agreement without amendment or waiver of any provision or condition thereof unless such amendment or waiver is not materially adverse to such Purchaser or such Purchaser consents to such
amendment or waiver. 
 (d) Governmental Permits and Approvals. All registrations, qualifications, permits
and approvals, if any, required to be obtained from any Governmental Entity prior to the Closing under applicable laws shall have been obtained for the lawful execution, delivery and performance of this Agreement or the other Transaction Documents,
including, without limitation, the offer and sale of the Securities. 
 (e) Amended and Restated Investor
Rights Agreement. The Amended and Restated Investor Rights Agreement shall have been executed and delivered by (i) Company and (ii) the Investors (as defined therein) other than such Purchaser. 
  

 - 21 - 








 (f) No Stockholder Approval Required. No approval on the part of the
stockholders of the Company shall be required in connection with the execution and delivery by the Company of the Certificates of Designation, this Agreement and the other Transaction Documents and the consummation of the transactions contemplated
hereby and thereby, other than any such approvals that shall have been obtained or waived. No shares of Common Stock shall be issued by the Company in connection with the Acquisition (within the meaning of the rules of the NASDAQ Stock Market)
without obtaining the prior approval of the stockholders of the Company of such issuance. 
 (g) Supporting
Documents. The Purchasers shall have received the following at or before the Closing: 
 (1) A good standing
certificate of the Company and each Subsidiary; 
 (2) An opinion from Goodwin Procter LLP, counsel to the
Company, dated as of the Closing Date, in a form satisfactory to the Purchasers; 
 (3) Copies of resolutions of
the Board of Directors of the Company (the “Board”), certified by the Secretary of the Company, authorizing and approving the filing of the Certificates of Designation, the execution, delivery and performance of the
Transaction Documents, the Acquisition Documents, the Financing Documents and all other documents and instruments to be delivered pursuant hereto and thereto; 
 (4) Copy of the Amended and Restated Certificate of Incorporation and By-laws of the Company, certified by the Secretary of
the Company; and 
 (5) A certificate of incumbency executed by the Secretary of the Company (A) certifying
the names, titles and signatures of the officers authorized to execute the documents referred to in subparagraphs (3) and (4) above and (B) further certifying that the Certificates of Designation delivered to the
Purchasers at the time of the execution of this Agreement have been validly adopted and have not been amended or modified. 
 (h) No Material Adverse Change. Since July 31, 2009 (with respect to the Target and its subsidiaries), and since August 31, 2009 (with respect to the Company and the Subsidiaries), no
events, circumstances or developments shall have occurred that, in the aggregate, would cause a material adverse change on the business, assets, liabilities, operations, results of operations or financial condition of the Company, the Target or any
of their subsidiaries, taken as a whole, other than any change or effect that results or arises from or relates to (i) (w) changes in economic, regulatory or political conditions, financial, securities or other market conditions or
prevailing interest rates, (x) acts of war, declared or undeclared, armed hostilities or acts of terrorism, (y) changes in

  

 - 22 - 








 
the industry in which the Company, the Target or any of their subsidiaries operates or (z) changes in (including changes in interpretation or application of) laws, regulations or accounting
standards, principles or interpretations, to the extent, in the cases of clauses (w), (x), (y) and (z), such changes or acts do not disproportionately affect the Company, Target or their subsidiaries, relative to other entities in the
Company’s, Target’s or any of their subsidiaries’ industry, (ii) seasonal variations in the Company’s, Target’s or any of their subsidiaries’ business or (iii) the announcement of the Acquisition or the
performance of obligations under the Stock Purchase Agreement, the Financing Commitments or the Transaction Documents; provided, that in no event shall the mere failure of the Company, the Target or any of their subsidiaries to meet budgeted or
projected revenues or earnings constitute, in and of itself, a material adverse change. 
 (i) Financings.
Simultaneously with or prior to the Closing hereunder, the consummation shall have occurred of the debt and equity financings on the terms and conditions described in (i) the Commitment Letter (the “Senior Commitment”)
between General Electric Capital Corporation and the Company dated October 16, 2009, (ii) the Commitment Letter (together with the Senior Commitment, the “Financing Commitments”) dated October 16, 2009 between
Sankaty Advisors, LLC and Falcon and the Company, (iii) as a condition to the obligations of each party other than Prides Capital only, the Commitment Letter (the “Prides Commitment”) between Prides Capital and the
Company dated October 16, 2009, and (iv) as a condition to the obligations of each party other than a Bain Fund only, the Commitment Letter (together with the Prides Commitment, the “Equity Commitments”) between
BCVF 2007 and the Company dated October 16, 2009, and otherwise on terms reasonably satisfactory to each Purchaser, provided that any modification, change or amendment to the terms or conditions of the Financing Commitments or the Equity
Commitments that is not materially adverse to a Purchaser shall not constitute a failure to satisfy this condition. 
 (j) Compliance Certificate. The Company shall have delivered to the Purchasers a Compliance Certificate, executed by the Chief Executive Officer of the Company, dated as of the Closing Date to the effect that the conditions specified
in subsections (a), (b)(i), (c), (f), (h) and (i) of this Section 6.1 have been satisfied. 
 6.2. Conditions of the Company’s Obligations. The obligations of the Company under Section 2 hereof are subject to the fulfillment prior to or on the Closing of all of the
following conditions, any of which may be waived in whole or in part by the Company. 
 (a) Covenants;
Representations and Warranties. Each of the Purchasers at the Closing shall have performed in all material respects all of its obligations and conditions hereunder required to be performed or complied by it at or prior to the Closing.

  

 - 23 - 








 (b) Amended and Restated Investor Rights Agreement. Each Purchaser
shall have executed and delivered the Amended and Restated Investor Rights Agreement. 
 6.3. Conditions of Each Party’s
Obligations. The respective obligations of each party to consummate the transactions at the Closing contemplated hereunder are subject to the parties being reasonably satisfied as to the absence of (a) litigation challenging or seeking
damages in connection with the transactions contemplated by this Agreement, any of the Transaction Documents or any of the Certificates of Designation, in which there has been issued any order or injunction delaying or preventing the consummation of
the transactions contemplated hereby, and (b) any statute, rule, regulation, injunction, order or decree, enacted, enforced, promulgated, entered, issued or deemed applicable to this Agreement or the transactions contemplated hereby by any
court, government or governmental authority or agency or legislative body, domestic, foreign or supranational prohibiting or enjoining the transactions contemplated by this Agreement. 
 7. Covenants. 
 7.1. Reporting Requirements; Access to Records. As long as any Purchaser holds at least five percent (5%) of its originally issued New Preferred Stock and the Company remains subject to the requirements of the Exchange Act, the
Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. The Company further agrees to
make available to each of Bain Capital and Prides Capital for so long as it holds at least five percent (5%) of its originally issued New Preferred Stock and any other Purchaser that holds New Preferred Stock representing at least five percent
(5%) of the issued and outstanding shares of Common Stock on an as-converted basis, (i) such information as the Company is required to file or furnish to the SEC, within the time periods required by applicable law and regulations for
filing or furnishing such information with the SEC, (ii) such information as it furnishes to its other shareholders, (iii) unless otherwise requested by Bain Capital, Prides Capital or such Purchaser, such information as it furnishes to
its Board and committee members, and (iv) reasonable access during normal business hours, upon reasonable advance notice, to all of the books, records and properties of the Company and its Subsidiaries, if any, and to all officers and employees
of the Company and such Subsidiaries (which access shall be given to Bain Capital, Prides Capital and any such Purchaser’s respective officers, employees, advisors, counsel and other authorized representatives). 
 7.2. Integration. The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any
security (as defined in Section 2 of the Securities Act) that would be integrated with the offer or sale of the Series E Preferred Stock in a manner that would require the registration under the Securities Act of the sale of the Series E
Preferred Stock to the Purchasers or that would be integrated with the offer or sale of the Series E Preferred Stock for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing
of such other transaction unless shareholder approval is obtained before the closing of such subsequent transaction. 
  

 - 24 - 








 7.3. Securities Laws Disclosure; Publicity. The Company shall, by 8:30 a.m. (New York
City time) on the fourth (4th) business day immediately following the date hereof, issue a Current Report on Form 8-K, disclosing the material terms of the transactions contemplated hereby and filing the Transaction Documents as exhibits
thereto. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue any such press release or otherwise
make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of the Company, which consent shall not
unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or communication. Notwithstanding the foregoing,
the Company shall not publicly disclose the name of any Purchaser, or include the name of any Purchaser in any filing with the SEC or any regulatory agency or Trading Market, without the prior written consent of such Purchaser, except (i) as
required by federal securities law in connection with (A) any registration statement contemplated by the Amended and Restated Investor Rights Agreement, (B) the Current Report on Form 8-K required by this Section 7.3,
(C) any filing required by the SEC and (D) the filing of final Transaction Documents (including signature pages thereto) with the SEC and (ii) to the extent such disclosure is required by law or Trading Market regulations, in which
case the Company shall provide the Purchasers with prior notice of such disclosure permitted under this clause (ii). 
 7.4. Reservation of Stock. The Company shall continue to reserve and keep available at all times, free of preemptive rights, out of its treasury stock or its authorized but unissued shares of capital stock, or both, a sufficient
number of shares of (i) Series D Preferred Stock for the purpose of enabling the Company to issue shares of Series D Preferred Stock following the Series E Preferred Stock Conversion Approval and (ii) Common Stock for the purpose of
enabling the Company to issue shares of Common Stock upon conversion of the Series D Preferred Stock. 
 7.5. Listing of
Common Stock. The Company hereby agrees to use best efforts to maintain the listing of the Common Stock on a Trading Market. The Company will take all action reasonably necessary to continue the listing and trading of its Common Stock on a
Trading Market and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. 
 7.6. Filings. The Company shall make all filings with the SEC and its Trading Markets as required by the transactions contemplated hereby. If at any time a Purchaser determines that a filing under
the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, is desirable or necessary and makes such a request of the Company, the Company will cooperate in making such filing and will pay for any and all filing fees and out-of-pocket
expenses incurred by such Purchaser in connection with any such filing. 
  

 - 25 - 








 7.7. Board Representation; Nomination of Chief Executive Officer. The Company
covenants and agrees that it will, in accordance with the Certificates of Designation, take all steps necessary to appoint two representatives of the holders of New Preferred Stock to the Board (the “Preferred Directors”),
who will initially be Michael A. Krupka and Jeffrey R. Crisan. The Company agrees that it will reimburse the Preferred Directors for costs and expenses in attending Board meetings. For so long as any shares of New Preferred Stock remain outstanding,
the Company shall take all reasonable measures to cause the Company’s Chief Executive Officer to be nominated and supported by the Company for election as a director, unless the holders of a majority of the shares of New Preferred Stock then
outstanding determine otherwise and so notify the Company in writing. 
 7.8. Board Committees. The Company covenants and
agrees that it will adjust the membership on its Board committees so that at least one of the Preferred Directors is a member of all committees of the Board, including the Compensation Committee and the Nominating Committee, but excluding the Audit
Committee. 
 7.9. Board Observer Rights. So long as Prides Capital and its Affiliates collectively own at least ten
percent (10%) of the number of shares of Series E Preferred Stock originally purchased by Prides Capital (and/or the shares of Series D Preferred Stock issued upon conversion thereof), the Company covenants and agrees that it will provide to
Prides Capital the privilege to appoint one (1) observer to the Board and all committees of the Board, provided that such observer shall be Stephen Cootey, Kevin A. Richardson, II, or such other individual designated by Prides Capital as
may be reasonably satisfactory to the Company. Once Prides Capital and its Affiliates collectively own less than ten percent (10%) of the number of shares of Series E Preferred Stock originally purchased by them (and/or the shares of Series D
Preferred Stock issued upon conversion thereof), and so long as Bain Capital owns at least ten percent (10%) of the number of shares of Series E Preferred Stock originally purchased by Bain Capital (and/or the shares of Series D Preferred Stock
issued upon conversion thereof), the Company covenants and agrees that it will provide to Bain Capital the privilege to appoint one (1) observer to the Board and all committees of the Board, provided that such observer designated by Bain
Capital shall be reasonably satisfactory to the Company. So long as BCVI and its Affiliates collectively own at least ten percent (10%) of the number of shares of Series E Preferred Stock originally purchased by BCVI (and/or the shares of
Series D Preferred Stock issued upon conversion thereof), the Company covenants and agrees that it will provide to Auda Private Equity LLC (“Auda”) the privilege to appoint one (1) observer to the Board and all
committees of the Board, provided that such observer designated by Auda shall be reasonably satisfactory to the Company. In the event that a designee of Falcon Strategic Partners III, LP (“Falcon”) is not a member of,
or an observer to, the Board, and so long as Falcon and its Affiliates collectively own at least ten percent (10%) of the aggregate number of shares of New Preferred Stock originally purchased by them hereunder, and granted to them pursuant to
the certain Securities 
  

 - 26 - 








 
Purchase Agreement, dated as of the date hereof, by and among the Company, Falcon and the other parties thereto (and/or, in each case, the shares of Series D Preferred Stock issued upon
conversion thereof), the Company covenants and agrees that it will provide to Falcon the privilege to appoint one (1) observer to the Board and all committees of the Board, provided that such observer designated by Falcon shall be
reasonably satisfactory to the Company. Subject to customary confidentiality restrictions, such observers will be provided with all information and materials provided to the directors and committee members, will be reimbursed for costs and expenses
incurred in attending meetings and will receive any other compensation paid by the Company to the directors appointed by the holders of New Preferred Stock. 
 7.10. Nomination Process. The Company covenants and agrees that it will follow the director nomination process as set forth in the By-laws attached as Exhibit E hereto. 
 7.11. Standstill on Change of Control. So long as Bain Capital holds shares of New Preferred Stock, Bain Capital agrees that if,
pursuant to Section 7 of the Series D Certificate of Designation or the Series E Certificate of Designation, the Required Holders (as defined in the Series D Certificate of Designation and the Series E Certificate of Designation), if requested
by the Board, do not consent to a bona fide offer by a third party to consummate a Change of Control (as defined in the Series D Certificate of Designation and the Series E Certificate of Designation) transaction approved by the Board, then Bain
Capital shall not, within twelve months of such request, present the Company with a Change of Control transaction in which a Bain Fund (as defined in the Series D Certificate of Designation and the Series E Certificate of Designation) will
participate as a buyer. 
 7.12. Termination of Agreement. This Agreement may be terminated at any time prior to the
Closing as follows: 
 (a) by mutual written consent of the Company and the Aggregate Holders; 
 (b) by either the Company or the Aggregate Holders by written notice to the other party, if the Closing shall not have
occurred on or before December 31, 2009 (the “End Date”); provided, that the right to terminate this Agreement under this Section 7.12(b) shall not be available to any party whose failure to fulfill
any obligation under this Agreement shall have been the cause of, or shall have resulted in, the failure of the Closing to occur on or prior to such date; 
 (c) by the Company, by written notice to the Purchasers, if a failure to perform any covenant or agreement on the part of the Purchasers set forth in this Agreement shall have occurred that would cause
the condition set forth in Section 6.2(a) not to be satisfied, and such breach is incapable of being cured by the End Date. 
  

 - 27 - 








 7.13. Effect of Termination. In the event of termination of this Agreement by a party
pursuant to Section 7.12, written notice thereof shall be given by the terminating party to the other parties, and this Agreement shall thereupon terminate and become void and of no effect, and the transactions contemplated hereby shall
be abandoned without further action by the parties, provided, that such termination shall not relieve any party of any liability for its breach of this Agreement prior to the effectiveness of such termination. 
 8. Transfer Restrictions; Restrictive Legend. 
 8.1. Transfer Restrictions. Each Purchaser understands that the Company may, as a condition to the transfer of any of the Securities, require that the request for transfer be accompanied by an
opinion of counsel reasonably satisfactory to the Company, to the effect that the proposed transfer does not result in a violation of the Securities Act, unless such transfer is covered by an effective registration statement or by Rule 144 or Rule
144A under the Securities Act; provided, however, that an opinion of counsel shall not be required for a transfer by a Purchaser that is (A) a partnership transferring to its partners or former partners in accordance with
partnership interests, (B) a corporation transferring to a wholly owned subsidiary or a parent corporation that owns all of the capital stock of the Purchaser, (C) a limited liability company transferring to its members or former members
in accordance with their interest in the limited liability company, (D) an individual transferring to the Purchaser’s family member or trust for the benefit of an individual Purchaser, or (E) transferring its Securities to any
Affiliate of the Purchaser, in the case of an institutional investor, or other Person under common management with such Purchaser; and provided, further, that the transferee in each case agrees to be subject to the restrictions in this
Section 8. It is understood that the certificates evidencing the Securities may bear substantially the following legends: 
 “THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT IN EFFECT WITH
RESPECT TO THE SECURITIES UNDER SUCH ACT OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED OR UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A OF SUCH ACT.” 
 8.2. Unlegended Certificates. The Company shall be obligated to promptly reissue unlegended certificates upon the request of any
holder thereof at such time as (i) a registration statement relating to the Securities is effective, or (ii) the holding period under Rule 144 or another applicable exemption from the registration requirements of the Securities Act has
been satisfied. The Company is entitled to request from any holder requesting unlegended certificates under (ii) above an opinion of counsel reasonably acceptable to the Company to the effect that the securities proposed to be disposed of may
lawfully be so disposed of without registration, qualification or legend. 
  

 - 28 - 








 9. Registration, Transfer and Substitution of Certificates for Securities.

 9.1. Stock Register; Ownership of Securities. The Company will keep at its principal office a register in which the
Company will provide for the registration of transfers of the Securities. The Company may treat the Person in whose name any of the Securities are registered on such register as the owner thereof and the Company shall not be affected by any notice
to the contrary. All references in this Agreement to a “holder” of any Securities shall mean the Person in whose name such Securities are at the time registered on such register. 
 9.2. Replacement of Certificates. Upon receipt of evidence reasonably satisfactory to the Company of the loss, theft, destruction or
mutilation of any certificate representing Securities, and, in the case of any such loss, theft or destruction, upon delivery of an indemnity agreement reasonably satisfactory to the Company or, in the case of any such mutilation, upon surrender of
such certificate for cancellation at the office of the Company maintained pursuant to Section 9.1 hereof, the Company at its expense will execute and deliver, in lieu thereof, a new certificate representing Securities of like tenor.

 10. Definitions. Unless the context otherwise requires, the terms defined in this Section 10 shall have
the meanings specified for all purposes of this Agreement. 
 Except as otherwise expressly provided, all accounting terms used
in this Agreement, whether or not defined in this Section 10, shall be construed in accordance with GAAP. If and so long as the Company has one or more Subsidiaries, such accounting terms shall be determined on a consolidated basis for
the Company and each of its Subsidiaries, and the financial statements and other financial information to be furnished by the Company pursuant to this Agreement shall be consolidated and presented with consolidating financial statements of the
Company and each of its Subsidiaries. 
 “Acquisition” has the meaning assigned to it in
Section 3.2 hereof. 
 “Acquisition Documents” means the Stock Purchase Agreement and all
exhibits thereto, together with all other agreements and instruments referred to therein. 
 “Affiliate”
shall have the meaning ascribed to such term in Rule 12b-2 of the General Rules and Regulations under the Exchange Act; provided, that with respect to Bain Capital, the term Affiliate shall also be deemed to include any Person under common
management with Bain Capital, LLC. 
 “Aggregate Holders” has the meaning assigned to it in
Section 13.1 hereof. 
 “Agreement” has the meaning assigned to it in the Preamble.

 “Amended and Restated Investor Rights Agreement” means the Amended and Restated Investor Rights
Agreement in the form attached hereto as Exhibit D. 
  

 - 29 - 








 “Auda” has the meaning assigned in it in Section 7.9
hereof. 
 “Bain Capital” has the meaning assigned to it in the Preamble. 
 “Bain Fund” has the meaning assigned to it in the Series E Certificate of Designation. 
 “Basket” has the meaning assigned in it in Section 13.3 hereof. 
 “BCVF 2007” has the meaning assigned to it in the Preamble. 
 “BCVI” has the meaning assigned to it in the Preamble. 
 “Benefit Plan” has the meaning assigned to it in Section 5.1(a) hereof. 
 “Board” has the meaning assigned to it in Section 6.1(g)(3) hereof. 
 “Certificates of Designation” has the meaning assigned to it in Section 1 hereof. 
 “Change of Control” has the meaning assigned to it in the Series E Certificate of Designation. 
 “Charter Documents” has the meaning assigned to it in Section 5.8 hereof. 
 “Closing” has the meaning assigned to it in Section 3.1 hereof. 
 “Closing Date” has the meaning assigned to it in Section 3.1 hereof. 
 “Code” means the Internal Revenue Code of 1986, as amended. 
 “Common Stock” has the meaning assigned to it in Section 1 hereof. 
 “Company” has the meaning assigned to it in the Preamble. 
 “Company Intellectual Property” has the meaning assigned to it in Section 5.21(a) hereof. 
 “Conversion Shares” has the meaning assigned to it in Section 1 hereof. 
 “Disclosure Schedule” has the meaning assigned to it in Section 5 hereof. 
 “Domain Names” has the meaning assigned to it in Section 5.21(c) hereof. 
 “Employee Benefit Plan” has the meaning assigned to it in Section 5.17(b) hereof. 
  

 - 30 - 








 “Encumbrances” has the meaning assigned to it in
Section 5.2 hereof. 
 “End Date” has the meaning assigned to it in
Section 7.12(b) hereof. 
 “Environmental Laws” has the meaning assigned to it in
Section 5.20(b) hereof. 
 “Equity Commitments” has the meaning assigned to it in
Section 6.1(i) hereof. 
 “ERISA” has the meaning assigned to it in
Section 5.17(a) hereof. 
 “Exchange Act” means the Securities Exchange Act of 1934, as
amended. 
 “Falcon” has the meaning assigned to it in Section 7.9 hereof. 
 “Financings” means the financing arrangements consummated pursuant to the Financing Documents. 
 “Financing Commitments” has the meaning assigned to it in Section 6.1(i) hereof. 
 “Financing Documents” means, collectively, the Financing Commitments and the Senior Financing Arrangements.

 “FINRA” means Financial Industry Regulatory Authority, Inc. 
 “GAAP” means U.S. generally accepted accounting principles consistently applied. 
 “Governmental Entity” means any national, federal, state, municipal, local, territorial, foreign or other government
or any department, commission, board, bureau, agency, regulatory authority or instrumentality thereof, or any court, judicial, administrative or arbitral body or public or private tribunal. 
 “Hazardous Material” has the meaning assigned to it in Section 5.20(b) hereof. 
 “Intellectual Property” has the meaning assigned to it in Section 5.21(a) hereof. 
 “knowledge of the Company” means the actual knowledge Michael J. Perik, Stephen C. Richards, Anthony J. Bordon, Neal
S. Winneg, Susan T. Rao and Daniel Conrad after reasonable inquiry. 
 “Losses” has the meaning assigned
to it in Section 13.3 hereof. 
  

 - 31 - 








 “Material Adverse Effect” means (i) any material adverse effect
on the issuance or validity of the Securities or the transactions contemplated hereby or the enforceability or validity of the Certificates of Designation or on the ability of the Company to perform its obligations under this Agreement and the other
Transaction Documents or (ii) any material adverse effect on the condition (financial or otherwise), properties, assets, liabilities, business or operations of the Company and its Subsidiaries, taken as a whole. 
 “Material Contract” means all written and oral contracts, agreements, deeds, mortgages, leases, subleases, licenses,
instruments, notes, commitments, commissions, undertakings, arrangements and understandings which are required to be filed as exhibits by the Company with the SEC pursuant to Items 601(b)(4) and 601(b)(10) of Regulation S-K promulgated by the SEC.

 “Material Permit” has the meaning assigned to it in Section 5.28 hereof. 
 “New Preferred Stock” has the meaning assigned to it in Section 1 hereof. 
 “NSI” has the meaning assigned to it in Section 5.21(c) hereof. 
 “Person” means and includes all natural persons, corporations, business trusts, associations, companies,
partnerships, joint ventures, limited liability companies and other entities and governments and agencies and political subdivisions. 
 “Post-2006 SEC Reports” has the meaning assigned it in Section 5.13(a) hereof. 
 “Preferred Directors” has the meaning assigned it in Section 7.7 hereof. 
 “Prides Capital” has the meaning assigned to it in the Preamble. 
 “Prides
Commitment” has the meaning assigned it in Section 6.1(i) hereof. 
 “Purchase
Price” has the meaning assigned it in Section 2 hereof. 
 “Purchaser” and
“Purchasers” have the meaning assigned to them in the Preamble and shall include any Affiliates of the Purchasers. 
 “Purchaser Indemnified Party” has the meaning assigned it in Section 13.3 hereof. 
 “SEC” means the U.S. Securities and Exchange Commission or any other federal agency then administering the Securities Act and other federal securities laws. 
 “SEC Reports” has the meaning assigned to it in Section 5.13(a) hereof. 
 “Securities” has the meaning assigned to it in Section 1 hereof. 
 “Securities Act” or “Act” means the Securities Act of 1933, as amended. 
  

 - 32 - 








 “Seller” has the meaning assigned to it in Section 3.2
hereof. 
 “Senior Commitment” has the meaning assigned to it in Section 6.1(i) hereof.

 “Senior Financing Arrangements” means the Senior Commitment and other financing arrangements entered
into by the Company and the other parties thereto at the Closing (as the same may be amended, supplemented or otherwise modified from time to time, including any syndication thereof up to $96 million) or any financing arrangements consummated to
extend, renew or refinance any such financing arrangements. 
 “Series C Preferred Stock” has the
meaning assigned to such term in the recitals hereof. 
 “Series D Certificate of Designation” has the
meaning assigned to such term in Section 1 hereof. 
 “Series D Preferred Stock” has the
meaning assigned to such term in Section 1 hereof. 
 “Series E Certificate of Designation”
has the meaning assigned to such term in Section 1 hereof. 
 “Series E Preferred Stock Conversion
Approval” has the meaning assigned to such term in the Series E Certificate of Designation. 
 “Series E
Preferred Stock” has the meaning assigned to such term in Section 1 hereof. 
 “Stock
Purchase Agreement” has the meaning assigned to it in Section 3.2 hereof. 
 “Subsidiary” means any corporation, association trust, limited liability company, partnership, joint venture or other business association or entity (i) at least fifty percent (50%) of the outstanding
voting securities of which are at the time owned or controlled directly or indirectly by the Company or (ii) with respect to which the Company possesses, directly or indirectly, the power to direct or cause the direction of the affairs or
management of such Person. 
 “Target” has the meaning assigned to such term in Section 3.2
hereof. 
 “Trading Market” means the following markets or exchanges on which the Common Stock is listed
or quoted for trading on the date in question: the American Stock Exchange, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, the New York Stock Exchange or the OTC Bulletin Board. 
  

 - 33 - 








 “Transaction Documents” means this Agreement and the Amended and
Restated Investor Rights Agreement. 
 11. Enforcement. 
 11.1. Cumulative Remedies. None of the rights, powers or remedies conferred upon the Purchasers on the one hand or the Company on the
other hand shall be mutually exclusive, and each such right, power or remedy shall be cumulative and in addition to every other right, power or remedy, whether conferred by this Agreement, any of the other Transaction Documents or the Certificates
of Designation or now or hereafter available at law, in equity, by statute or otherwise. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company
will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the Transaction Documents
and hereby agree to waive and not to assert in any action for specific performance of any such obligation the defense that a remedy at law would be adequate. 
 11.2. No Implied Waiver. Except as expressly provided in this Agreement, no course of dealing between the Company and the Purchasers or any other holder of shares of New Preferred Stock and no
delay in exercising any such right, power or remedy conferred hereby or by the Certificates of Designation, or by any of the other Transaction Documents or now or hereafter existing at law in equity, by statute or otherwise, shall operate as a
waiver of, or otherwise prejudice, any such right, power or remedy. 
 12. Confidentiality. Except as otherwise agreed in
writing by the Company, each Purchaser agrees that it will use reasonable care to keep confidential and not disclose, divulge, or use for any purpose (other than to monitor its investment in the Company) any confidential information obtained from
the Company pursuant to the terms of the Transaction Documents (including notice of the Company’s intention to file a registration statement), unless such confidential information (a) is known or becomes known to the public in general
(other than as a result of a breach of this Section 12 by such Purchaser), (b) is or has been independently developed or conceived by the Purchaser without use of the Company’s confidential information, (c) is or has been
made known or disclosed to the Purchaser by a third party without a breach of any obligation of confidentiality such third party may have to the Company or (d) was known to the Purchaser prior to disclosure to the Purchaser by the Company;
provided, however, that a Purchaser may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its
investment in the Company; (ii) to any prospective purchaser of any Securities from such Purchaser, if such prospective purchaser agrees to be bound by the provisions of this Section 12; (iii) to any Affiliate, partner, member,
stockholder or advisor of such Purchaser in the ordinary course of business, provided that such Purchaser informs such person that such information is confidential and directs such person to maintain the confidentiality of such information;
or (iv) as

  

 - 34 - 








 
may otherwise be required by law, provided that the Purchaser promptly notifies the Company of such disclosure and, if requested by the Company, reasonably cooperates with the Company at
the Company’s expense to minimize the extent of any such required disclosure. Notwithstanding anything to the contrary herein, the confidentiality obligations of this Section 12 shall survive the termination of this Agreement.

 13. Miscellaneous. 
 13.1. Waivers and Amendments. Upon the approval of the Company and the written consent of the Purchasers (a) with the right to acquire at least eighty-five percent (85%) of the Series E
Preferred Stock prior to the Closing or (b) holding at least eighty-five percent (85%) of the New Preferred Stock following the Closing (the “Aggregate Holders”), (i) the obligations of the Company and the
rights of the Purchasers under this Agreement may be waived (either generally or in a particular instance, either retroactively or prospectively and either for a specified period of time or indefinitely), and (ii) the Company may enter into a
supplementary agreement for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Agreement, or of any supplemental agreement or modifying in any manner the rights and obligations hereunder or
thereunder of the Purchasers and/or the Company; provided, however, that, without a Purchaser’s consent, any such amendment or waiver shall not treat such Purchaser differently from any other Purchaser. The Company shall deliver
copies of such consent to any Purchasers who did not execute the same. 
 The foregoing notwithstanding, no such waiver or
supplemental agreement shall affect any of the rights of any holder of any Securities created by (1) the Certificates of Designation or by the Delaware General Corporation Law without compliance with all applicable provisions of the
Certificates of Designation and the Delaware General Corporation Law or (2) any Transaction Document other than this Agreement without compliance with all applicable provisions of such Transaction Document. 
 Neither this Agreement, nor any provision hereof, may be changed, waived, discharged or terminated orally or by course of dealing, but only
by an instrument in writing. 
 13.2. Notices. All notices, requests, consents, and other communications under this
Agreement shall be in writing and shall be deemed delivered (a) three (3) business days after being sent by registered or certified mail, return receipt requested, postage prepaid or (b) one (1) business day after being sent via
a reputable nationwide overnight courier service guaranteeing next business day delivery, in each case to the intended recipient as set forth below: 
 If to a Purchaser at its address set forth on Schedule I hereto. 
 with a
copy to: 
 Ropes & Gray LLP 
 One International Place 
 Boston, MA 02110 
 Attention: Joel F. Freedman, Esq. 
 Facsimile No.: (617) 951-7050; 
  

 - 35 - 








 Simpson Thacher & Bartlett LLP 
 2550 Hanover Street 
 Palo Alto, CA 94304 
 Attention: Michael J. Nooney, Esq. 
 Facsimile No.: (650) 251-5002 
 and 
 Kirkland & Ellis LLP 
 601 Lexington Avenue 
 New York, NY 10022-4675 
 Attention: Srinivas Kaushik, Esq. 
 Joshua Kogan, Esq. 
 Facsimile No.: (212) 446-6460 
 If to the Company: 
 The Princeton Review, Inc. 
 111 Speen Street 
 Framingham, MA 01701 
 Attention: General Counsel 
 Facsimile No.: (508) 663-5115 
 with a copy to: 
 Goodwin Procter LLP. 
 Exchange Place, 53 State St. 
 Boston, MA 
 Attention: John M. Mutkoski, Esq. 
 Edward A King, Esq. 
 Facsimile No.: (617) 523-1231 
 or at such other address as the Company or the Purchasers each may specify by written notice to the other parties hereto. Any party may give any notice,
request, consent or other communication under this Agreement using any other means (including, without limitation, personal delivery, messenger service, telecopy, first class mail or electronic mail), but no such notice, request, consent or other
communication shall be deemed to have been duly given unless

  

 - 36 - 








 
and until it is actually received by the party for whom it is intended. Any party may change the address to which notices, requests, consents or other communications hereunder are to be delivered
by giving the other parties notice in the manner set forth in this Section 13.2. 
 13.3. Indemnification;
Survival. The Company shall indemnify, save and hold harmless each Purchaser, its directors, officers, employees, partners, representatives and agents (each, a “Purchaser Indemnified Party”) from and against (and shall
promptly reimburse such indemnified persons for) any and all liability, loss, cost, damage, reasonable attorneys’ and accountants’ fees and expenses, court costs and all other out-of-pocket expenses incurred (collectively,
“Losses”) in connection with or arising from claims, actions, suits, proceedings or similar claims by any person or entity (other than such Purchaser) associated, arising out of or relating to (i) the execution, delivery
and performance of this Agreement, any of the other Transaction Documents or any of the Certificates of Designation, (ii) the transactions contemplated hereby or thereby, (iii) the ownership by such Purchaser of the Securities or
(iv) the rights of the Purchasers to elect directors to the Board. This indemnification provision shall be in addition to the rights of the Purchasers to bring an action against the Company for breach of any term of this Agreement, the other
Transaction Documents or any of the Certificates of Designation. Notwithstanding anything herein to the contrary, (i) the Company shall not be obligated to indemnify any Purchaser Indemnified Party under this Section 13.3 with
respect to Losses arising out of, relating to, or resulting from any breach of a representation or warranty contained in this Agreement or the Transaction Documents unless the aggregate of all such Losses for such Purchaser Indemnified Party exceeds
$100,000 (the “Basket”), in which case such Purchaser Indemnified Party shall be entitled to recover all Losses in excess of the Basket, and (ii) the aggregate liability of the Company hereunder in respect of Losses
arising out of, relating to, or resulting from any breach of a representation or warranty contained in this Agreement or the Transaction Documents for any Purchaser Indemnified Party shall not exceed the total Purchase Price paid by such Purchaser
Indemnified Party. For purposes of the foregoing sentence only, the term “Purchase Price” shall mean $1,000 per share of Series E Preferred Stock in cash (regardless of whether the actual consideration paid by any Purchaser Indemnified
Party included cash or securities). All representations and warranties in this Agreement or the Transaction Documents shall survive the Closing (unless a different period is specifically assigned thereto) except (i) the representations and
warranties contained in this Agreement and the Transaction Documents, other than the representations and warranties contained in Section 5.38 of this Agreement, shall survive the Closing only until the date that is eighteen months after
the Closing Date, and (ii) the representations and warranties contained in Section 5.38 of this Agreement shall survive the Closing only until the date that is (x) eighteen months after the Acquisition closing date if the
breach of such representations and warranties arise out of or relate to the representations and warranties of Target and Seller in Sections 7.1, 7.2, 8.1(a), 8.2, 8.3, 8.13, 8.21 and 8.23 of the Stock Purchase Agreement and (y) twelve months
after the Acquisition closing date if the breach of such representations and warranties arise out of or relate to any of the other representations and warranties of Target and Seller in the Stock Purchase Agreement and the Acquisition Documents.

  

 - 37 - 








 13.4. No Waivers. No failure or delay by any party in exercising any right, power or
privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided
shall be cumulative and not exclusive of any rights or remedies provided by law. 
 13.5. Successors and Assigns. All the
terms and provisions of this Agreement shall be binding upon and inure to the benefit of and be enforceable by the respective parties hereto, the successors and permitted assigns of each Purchaser and the successors of the Company, whether so
expressed or not. None of the parties hereto may assign its rights or obligations under Section 2 hereof without the prior written consent of the Company, except that each Purchaser may, without the prior consent of the Company, assign
its rights to purchase the shares of Series E Preferred Stock hereunder to any of its Affiliates. This Agreement shall not inure to the benefit of or be enforceable by any other Person. 
 13.6. Headings. The headings of the Sections and paragraphs of this Agreement have been inserted for convenience of reference only
and do not constitute a part of this Agreement. 
 13.7. Governing Law. This Agreement shall be governed by and construed
in accordance with the laws of the State of New York, without regard to its conflict of law principles. 
 13.8. Independent
Nature of Purchasers’ Obligations and Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the
performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to
constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it
shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in their review and negotiation of the Transaction
Documents. Each Purchaser acknowledges that Ropes & Gray LLP has only acted as counsel for Bain Capital, Simpson Thacher & Bartlett LLP has only acted as counsel for Prides Capital and Kirkland & Ellis LLP has only acted
as counsel for Falcon and, in each case, not any other Purchaser. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company and not because it was required or requested to do
so by the Purchasers. 
  

 - 38 - 








 13.9. Fees and Expenses. The Company agrees to pay, reimburse and hold the Purchasers
harmless from liability for the payment of all out-of-pocket fees and expenses incurred by it in connection with its diligence investigation of the Company, the preparation and negotiation of this Agreement and the consummation of the transactions
contemplated hereby, regardless of whether the purchase of shares of Series E Preferred Stock by the Purchasers pursuant to this Agreement is consummated. An estimate of the fees and expenses of third parties may be paid by checks delivered or wire
transfers to such parties at the Closing by the Purchasers, the amount of such checks or wire transfers being deducted from the aggregate amount to be paid by such Purchasers at the Closing for the shares of Series E Preferred Stock to be purchased
by them hereunder. The reasonable fees and expenses of the Purchasers may include, without limitation: 
 (a) the
fees and expenses of counsel, consultants and accountants and out-of-pocket expenses, including diligence and travel expenses, of the Purchasers, arising in connection with the preparation, negotiation and execution of the Certificates of
Designation and the Transaction Documents and the consummation of the transactions contemplated thereby, 
 (b)
all costs of the Company’s performance and compliance with the Certificates of Designation or the Transaction Documents, and 
 (c) stamp and other taxes, excluding income taxes, which may be payable with respect to the execution and delivery of the Certificates of Designation or the Transaction Documents, or the issuance,
delivery or acquisition of the shares of New Preferred Stock or upon the conversion of the shares of New Preferred Stock. 
 In addition, the
Company agrees to pay Bain Capital Venture Partners, LLC and BCVI a transaction fee equal to $510,000 and $190,000, respectively. Such fees may be deducted from the aggregate amount to be paid by BCVI at the Closing for the shares of Series E
Preferred Stock to be purchased by it hereunder. 
 13.10. Jurisdiction. Any suit, action or proceeding seeking to
enforce any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated hereby shall be brought in any federal or state court located in the State of New York, and each of the parties
hereby consents to the jurisdiction of such courts (and of the appropriate appellate courts therefrom) in any such suit, action or proceeding and irrevocably waives, to the fullest extent permitted by law, any objection which it may now or hereafter
have to the laying of the venue of any such suit, action or proceeding in any such court or that any such suit, action or proceeding which is brought in any such court has been brought in an inconvenient forum. Process in any such suit, action or
proceeding may be served on any party anywhere in the world, whether within or without the jurisdiction of any such court. Without limiting the foregoing, each party agrees that service of process on such party as provided in
Section 13.2 shall be deemed effective service of process on such party. 
  

 - 39 - 








 13.11. Waiver of Jury Trial. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH
CANNOT BE WAIVED, THE PURCHASERS AND THE COMPANY HEREBY WAIVE, AND COVENANT THAT NEITHER THE COMPANY NOR THE PURCHASERS WILL ASSERT, ANY RIGHT TO TRIAL BY JURY ON ANY ISSUE IN ANY PROCEEDING, WHETHER AS PLAINTIFF, DEFENDANT OR OTHERWISE, IN RESPECT
OF ANY ISSUE, CLAIM, DEMAND, ACTION OR CAUSE OF ACTION ARISING OUT OF OR BASED UPON THIS AGREEMENT, ANY OTHER AGREEMENT OR THE SUBJECT MATTER HEREOF OR THEREOF OR IN ANY WAY CONNECTED WITH, RELATED OR INCIDENTAL TO THE DEALINGS OF THE PURCHASERS AND
THE COMPANY HEREUNDER OR THEREUNDER, IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING AND WHETHER IN TORT OR CONTRACT OR OTHERWISE. The Company acknowledges that it has been informed by the Purchasers that the provisions of this
Section 13.11 constitute a material inducement upon which the Purchasers are relying and will rely in entering into this Agreement. Any Purchaser or the Company may file an original counterpart or a copy of this Section 13.11
with any court as written evidence of the consent of the Purchasers and the Company to the waiver of the right to trial by jury. 
 13.12. Counterparts; Effectiveness. This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts, with the same effect as if all parties had signed the same document. All such
counterparts shall be deemed an original, shall be construed together and shall constitute one and the same instrument. This Agreement shall become effective when each party hereto shall have received counterparts hereof signed by all of the other
parties hereto. 
 13.13. Entire Agreement. The Certificates of Designation and the Transaction Documents contain the
entire agreement among the parties hereto with respect to the subject matter hereof and thereof and such agreements supersede and replace all other prior agreements, written or oral, among the parties hereto with respect to the subject matter hereof
and thereof. 
 13.14. Severability. If any provision of this Agreement shall be found by any court of competent
jurisdiction to be invalid or unenforceable, the parties hereby waive such provision to the extent that it is found to be invalid or unenforceable. Such provision shall, to the maximum extent allowable by law, be modified by such court so that it
becomes enforceable, and, as modified, shall be enforced as any other provision hereof, all the other provisions hereof continuing in full force and effect. 
 [Remainder of Page Intentionally Left Blank] 
  

 - 40 - 








 IN WITNESS WHEREOF, the parties hereto have caused this Series E Preferred Stock Purchase
Agreement to be duly executed as of the day and year first above written. 
  

			
	THE COMPANY
	
	THE PRINCETON REVIEW, INC.
		
	By:	 	 /s/ Stephen Richards

	Name:	 	Stephen Richards
	Title:	 	Chief Operating Officer and Chief Financial Officer


 [Signature page to Series E Preferred Stock Purchase Agreement] 








			
	THE PURCHASERS:
	
	BAIN CAPITAL VENTURE FUND 2007, L.P.
		
	By:	 	 Bain Capital Venture Partners, L.P.,
 its general partner

	By:	 	 Bain Capital Investors, LLC,
 its general partner

		
	By:	 	 /s/ Jeffrey Crisan

	Name:	 	Jeffrey Crisan
	Title:	 	Managing Director
	
	BCVI-TPR INTEGRAL L.P.
		
	By:	 	Bain Capital Venture Investors, LLC
		
	By:	 	 /s/ Jeffrey Crisan

	Name:	 	Jeffrey Crisan
	Title:	 	Managing Director
	
	BCIP VENTURE ASSOCIATES
		
	By:	 	 Bain Capital Investors, LLC,
 its managing partner

	By:	 	 Bain Capital Venture Investors, LLC,
 its attorney-in-fact

		
	By:	 	 /s/ Jeffrey Crisan

	Name:	 	Jeffrey Crisan
	Title:	 	Managing Director
	
	BCIP VENTURE ASSOCIATES-B
		
	By:	 	 Bain Capital Investors, LLC,
 its managing partner

	By:	 	 Bain Capital Venture Investors, LLC,
 its attorney-in-fact

		
	By:	 	 /s/ Jeffrey Crisan

	Name:	 	Jeffrey Crisan
	Title:	 	Managing Director
	
	RGIP, LLC
		
	By:	 	 /s/ Ann L. Milner

	Name:	 	Ann L. Milner
	Title:	 	Managing Member


 [Signature page to Series E Preferred Stock Purchase Agreement] 








			
	PRIDES CAPITAL FUND I LP
		
	By:	 	 Prides Capital Partners, L.L.C.,
 its general partner

		
	By:	 	 /s/ Kevin A. Richardson, II

	Name:	 	Kevin A. Richardson, II
	Title:	 	Managing Member


 [Signature page to Series E Preferred Stock Purchase Agreement] 








			
	FALCON STRATEGIC PARTNERS III, LP
		
	By:	 	 Falcon Strategic Investments III, LP,
 its general partner

	By:	 	 Falcon Strategic Investments GP III, LLC,
 its general partner

		
	By:	 	 /s/ John S. Schnabel

	Name:	 	John S. Schnabel
	Title:	 	Director
	
	FALCON MEZZANINE PARTNERS II, LP
		
	By:	 	 Falcon Mezzanine Investments II, LLC,
 its general partner

		
	By:	 	 /s/ John S. Schnabel

	Name:	 	John S. Schnabel
	Title:	 	Vice President
	
	FMP II CO-INVESTMENT, LLC
		
	By:	 	 /s/ John S. Schnabel

	Name:	 	John S. Schnabel
	Title:	 	Vice President


 [Signature page to Series E Preferred Stock Purchase Agreement] 







 SCHEDULE I 
  

									
	  	  	Shares of Series E
Preferred Stock
Purchased	  	Total
Purchase Price	  	Consideration
	 Purchaser
	  	  	  	Cash	  	Shares of
Series C
Preferred
Stock
	 Bain Capital Venture Fund 2007, L.P.
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617)
516-2010
	  	31,153.5	  	$31,153,500	  		  	34,615
					
	 BCVI-TPR Integral L.P.
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010
	  	25,000	  	$25,000,000	  	$25,000,000	  	
					
	 BCIP Venture Associates
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010
	  	4,403.7	  	$4,403,700	  		  	4,893
					
	 BCIP Venture Associates-B
 c/o Bain Capital, LLC
 111 Huntington Avenue
 Boston, MA 02199
 Facsimile No: (617) 516-2010
	  	82.8	  	$82,800	  		  	92
					
	 Prides Capital Fund I LP
 c/o Prides Capital Partners, L.L.C.
 200 High Street, Suite 700
 Boston, MA 02110
 Facsimile No: (617) 778-9299
	  	18,000	  	$18,000,000	  		  	20,000
					
	 RGIP, LLC
 c/o Ropes
& Gray LLP
 One International Place
 Boston, MA 02110
 Attn: Joel F. Freedman, Esq.
 Facsimile No: (617) 951-7050
	  	360	  	$360,000	  		  	400
					
	 Falcon Strategic Partners III, LP
 c/o Falcon Investment Advisors, LLC
 450 Park Avenue, Suite 1001
 New York, NY 10022
 Attn: John S.
Schnabel
 Facsimile No: (212) 300-0299
	  	12,714.3	  	$12,714,285.71	  	$12,714,285.71	  	
					
	 Falcon Mezzanine Partners II, LP
 c/o Falcon Investment Advisors, LLC
 450 Park Avenue, Suite 1001
 New York, NY 10022
 Attn: John S. Schnabel
 Facsimile No: (212) 300-0299
	  	2,268.6	  	$2,268,571.43	  	$2,268,571.43	  	
					
	 FMP II Co-Investment, LLC
 c/o Falcon Investment Advisors, LLC
 450 Park Avenue, Suite 1001
 New York, NY 10022
 Attn: John S. Schnabel
 Facsimile No: (212) 300-0299
	  	17.1	  	$17,142.86	  	$17,142.86	  	








 EXHIBIT A 
 SERIES E CERTIFICATE OF DESIGNATION 







 EXHIBIT B 
 SERIES D CERTIFICATE OF DESIGNATION 







 EXHIBIT C 
 CERTIFICATE OF ELIMINATION 







 EXHIBIT D 
 AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 







 EXHIBIT E 
 COMPANY BY-LAWS